The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer

Jill M. Kolesar, Suzanne E. Dahlberg, Sharon Marsh, Howard L. McLeod, David H. Johnson, Steven M. Keller, Joan H. Schiller

Research output: Contribution to journalArticle

17 Scopus citations

Fingerprint Dive into the research topics of 'The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences